Ribon Therapeutics
Cambridge, United States· Est.
Ribon Therapeutics is a clinical-stage biotechnology company developing small molecule therapeutics targeting mono-ADP-ribose polymerases for oncology and inflammation.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $25M
About
Ribon Therapeutics is a clinical-stage biotechnology company developing small molecule therapeutics targeting mono-ADP-ribose polymerases for oncology and inflammation.
OncologyImmunologySmall Molecules
Funding History
1Total raised:$25M
PIPE$25M